Help Center

[CMS124v6] NQF 0032 Cervical Cancer Screening

Last Updated: May 17, 2018 09:29AM PDT

Contents
1Measure Details
2. Measure Parameters
3. Meeting the Measure in Elation
4. Measure Information


1. Measure Details:
Report on the percentage of women 21-64 years of age who were screened for cervical cancer.

2. Measure Parameters:
Numerator: Women with one or more screenings for cervical cancer. Appropriate screenings are defined by any one of the following criteria:
- Cervical cytology performed during the measurement period or the two years prior to the measurement period for women who are at least 21 years old at the time of the test
- Cervical cytology/human papillomavirus (HPV) co-testing performed during the measurement period or the four years prior to the measurement period for women who are at least 30 years old at the time of the test.

Denominator: Women 23-64 years of age with a visit during the measurement period.

Exclusions/Exceptions: Women who had a hysterectomy with no residual cervix.

3. Elation Workflows
Recording from a visit note:
1/ Elation's Clinical Decision Support Feature allows you to easily document screenings. When a patient is due for a Cervical Cancer Screen, an alert will report at the top of the patient's visit note. Selecting Address on any of these will give a set of options to address that Quality Measure:




Addressing patients outside of a visit note:
1/
For a patient in the denominator, scroll to the bottom of their clinical profile, where their Health Maintenance items appear.

 
2/ Click on Cervical Cancer Screening, and indicate the date of the patient’s most recent Pap Smear and/or HPV test, enter result of test, and click Save New.


OR:

1/ Tag a report in the patient’s record with the approved document tag(s). This alone will meet the health maintenance requirement.

4 Document Tags that will satisfy this measure.


4. Measure Information
All women are at risk for cervical cancer, but it occurs most often in women over the age of 30. In 2015, approximately 12,900 women were diagnosed with cervical cancer in the U.S., resulting in an estimated 4,100 deaths (National Cancer Institute 2015). If pre-cancerous lesions are detected early by Pap tests and treated, the likelihood of survival is nearly 100 percent (American Cancer Society 2015). In 2013, women with no health insurance and recent immigrants were least likely to have a Pap test (American Cancer Society 2015).
support@elationpassport.com
http://assets0.desk.com/
false
desk
Loading
seconds ago
a minute ago
minutes ago
an hour ago
hours ago
a day ago
days ago
about
false
Invalid characters found
/customer/en/portal/articles/autocomplete